PL3766876T3 - Preparat farmaceutyczny zawierający pochodną chinolonu - Google Patents

Preparat farmaceutyczny zawierający pochodną chinolonu

Info

Publication number
PL3766876T3
PL3766876T3 PL20191961.0T PL20191961T PL3766876T3 PL 3766876 T3 PL3766876 T3 PL 3766876T3 PL 20191961 T PL20191961 T PL 20191961T PL 3766876 T3 PL3766876 T3 PL 3766876T3
Authority
PL
Poland
Prior art keywords
pharmaceutical formulation
formulation containing
quinolone derivative
quinolone
derivative
Prior art date
Application number
PL20191961.0T
Other languages
English (en)
Inventor
Roger Hanselmann
Maxwell M. Reeve
Graham Johnson
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of PL3766876T3 publication Critical patent/PL3766876T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/027—Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/037—Gearboxes for accommodating differential gearings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H48/00—Differential gearings
    • F16H48/06—Differential gearings with gears having orbital motion
    • F16H48/08—Differential gearings with gears having orbital motion comprising bevel gears
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/0457—Splash lubrication
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/048—Type of gearings to be lubricated, cooled or heated
    • F16H57/0482—Gearings with gears having orbital motion
    • F16H57/0483—Axle or inter-axle differentials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/19—Gearing
    • Y10T74/19642—Directly cooperating gears
    • Y10T74/19688—Bevel
    • Y10T74/19693—Motor vehicle drive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/21—Elements
    • Y10T74/2186—Gear casings
    • Y10T74/2188—Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PL20191961.0T 2008-09-24 2009-09-23 Preparat farmaceutyczny zawierający pochodną chinolonu PL3766876T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24

Publications (1)

Publication Number Publication Date
PL3766876T3 true PL3766876T3 (pl) 2024-04-02

Family

ID=42060333

Family Applications (2)

Application Number Title Priority Date Filing Date
PL20191961.0T PL3766876T3 (pl) 2008-09-24 2009-09-23 Preparat farmaceutyczny zawierający pochodną chinolonu
PL17163383T PL3214083T3 (pl) 2008-09-24 2009-09-23 Proces wytwarzania związków chinolonowych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17163383T PL3214083T3 (pl) 2008-09-24 2009-09-23 Proces wytwarzania związków chinolonowych

Country Status (28)

Country Link
US (3) US8497378B2 (pl)
EP (3) EP3766876B8 (pl)
JP (2) JP6013734B2 (pl)
KR (3) KR101775304B1 (pl)
CN (2) CN102164912B (pl)
AU (1) AU2009297085B2 (pl)
BR (1) BRPI0919241B8 (pl)
CA (1) CA2738236C (pl)
CY (2) CY1123658T1 (pl)
DK (2) DK2346855T3 (pl)
ES (3) ES2826273T3 (pl)
FI (2) FI3766876T3 (pl)
HK (1) HK1214243A1 (pl)
HR (1) HRP20201879T1 (pl)
HU (2) HUE052219T2 (pl)
IL (1) IL211845A (pl)
LT (3) LT3766876T (pl)
MX (3) MX2011003122A (pl)
NL (1) NL301091I2 (pl)
NO (1) NO2021006I1 (pl)
PL (2) PL3766876T3 (pl)
PT (1) PT3214083T (pl)
RS (1) RS61194B1 (pl)
RU (1) RU2546667C2 (pl)
SG (1) SG10201605492YA (pl)
SI (1) SI3214083T1 (pl)
SM (1) SMT202000690T1 (pl)
WO (1) WO2010036329A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
PT3214083T (pt) * 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona
WO2014152317A2 (en) * 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating gonorrhea infections using quinolone antibiotics
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
JP6813665B2 (ja) 2017-03-31 2021-01-13 富士フイルム株式会社 4−ピリドン化合物またはその塩、それを含む医薬組成物および剤
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
ES2200439T3 (es) 1995-09-22 2004-03-01 Wakunaga Pharmaceutical Co., Ltd. Intermedios para utilizar en la preparacion de nuevos derivados del acido piridonocarboxilico o sus sales.
MXPA02000103A (es) * 1999-07-01 2003-07-21 Wakunaga Pharma Co Ltd Derivado de acido quinolin carboxilico o sales del mismo.
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
EP1789392A2 (en) 2004-07-30 2007-05-30 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
US7728143B2 (en) 2004-10-08 2010-06-01 Abbott Laboratories Salt and crystalline forms thereof of a drug
SI1868581T1 (sl) 2005-04-11 2012-06-29 Abbott Lab Farmacevtski sestavki z izboljšanim profilom topnosti za slabo topna zdravila
PT3214083T (pt) 2008-09-24 2020-12-04 Melinta Subsidiary Corp Processo de preparação compostos de quinolona

Also Published As

Publication number Publication date
CN105001207A (zh) 2015-10-28
CY1123658T1 (el) 2021-05-05
EP2346855A2 (en) 2011-07-27
EP3766876B1 (en) 2023-09-13
AU2009297085B2 (en) 2015-07-09
US8497378B2 (en) 2013-07-30
NL301091I2 (nl) 2021-08-03
BRPI0919241B8 (pt) 2021-05-25
FIC20210002I1 (fi) 2021-02-16
PT3214083T (pt) 2020-12-04
LTC3214083I2 (lt) 2022-06-27
RU2011116052A (ru) 2012-10-27
US20120041208A1 (en) 2012-02-16
SMT202000690T1 (it) 2021-01-05
IL211845A0 (en) 2011-06-30
CY2021004I2 (el) 2021-05-05
MX377930B (es) 2025-03-10
FI3766876T3 (fi) 2023-12-05
IL211845A (en) 2017-03-30
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
CA2738236C (en) 2016-11-15
ES2826273T3 (es) 2021-05-17
EP3214083A1 (en) 2017-09-06
HK1244481A1 (en) 2018-08-10
USRE46617E1 (en) 2017-11-28
US20140171648A1 (en) 2014-06-19
CN102164912B (zh) 2015-08-19
BRPI0919241A8 (pt) 2017-10-17
HRP20201879T1 (hr) 2021-01-22
BRPI0919241A2 (pt) 2016-06-21
NL301091I1 (nl) 2021-02-10
HUS2100004I1 (hu) 2021-03-01
PL3214083T3 (pl) 2021-04-06
HK1214243A1 (zh) 2016-07-22
SI3214083T1 (sl) 2021-02-26
EP3214083B1 (en) 2020-09-16
CN102164912A (zh) 2011-08-24
NO2021006I1 (no) 2021-02-15
EP3766876A1 (en) 2021-01-20
US8871938B2 (en) 2014-10-28
LTPA2021002I1 (lt) 2021-03-10
KR20160116020A (ko) 2016-10-06
ES2966093T3 (es) 2024-04-18
BRPI0919241B1 (pt) 2020-05-12
MX2011003122A (es) 2011-07-20
CY2021004I1 (el) 2021-05-05
WO2010036329A3 (en) 2010-07-01
CA2738236A1 (en) 2010-04-01
MX2020009790A (es) 2020-10-12
JP6013734B2 (ja) 2016-10-25
EP3766876B8 (en) 2023-10-18
SG10201605492YA (en) 2016-09-29
EP2346855A4 (en) 2012-07-04
DK2346855T3 (en) 2017-07-24
KR101775304B1 (ko) 2017-09-05
LT3766876T (lt) 2023-12-11
ES2629466T3 (es) 2017-08-09
HUE052219T2 (hu) 2021-04-28
LT3214083T (lt) 2021-01-25
JP2015178515A (ja) 2015-10-08
RS61194B1 (sr) 2021-01-29
AU2009297085A1 (en) 2010-04-01
KR20170039758A (ko) 2017-04-11
EP2346855B1 (en) 2017-04-05
JP2012508161A (ja) 2012-04-05
DK3214083T3 (da) 2020-12-07
WO2010036329A2 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
EP3766876B8 (en) Pharmaceutical formulation containing a quinolone derivative
GB2450753B (en) New Pharmaceutical formulation
PL2468281T3 (pl) Kompozycja farmaceutyczna zawierająca pochodną chinoliny
ZA201104336B (en) Pharmaceutical compounds
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
ZA201200719B (en) Pharmaceutical formulation
ZA201006029B (en) Pharmaceutical dosage form
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
ZA201008584B (en) A pharmaceutical composition comprising rebamipide
GB0816371D0 (en) Pharmaceutical compounds
ZA201104348B (en) Pharmaceutical preparation
GB0812969D0 (en) Pharmaceutical compounds
ZA201008543B (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug
PT2271618E (pt) Compostos farmacêuticos
GB0816370D0 (en) Pharmaceutical compounds
GB0810857D0 (en) Pharmaceutical compounds
ZA201008115B (en) A solid pharmaceutical formulation
EP2364706A4 (en) PHARMACEUTICAL ACTIVE WITH CHINOLITE CONNECTION
GB0805292D0 (en) Pharmaceutical formulation
GB0705030D0 (en) Pharmaceutical formulation
GB0802252D0 (en) Pharmaceutical compounds
GB0820820D0 (en) Pharmaceutical compounds
GB0820825D0 (en) Pharmaceutical compounds